[Federal Register Volume 59, Number 73 (Friday, April 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-9075]


[[Page Unknown]]

[Federal Register: April 15, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
 

National Cancer Institute; Meeting of the Developmental 
Therapeutics Contracts Review Committee

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Developmental Therapeutics Contracts Review Committee, 
National Cancer Institute, National Institutes of Health, on May 5, 
1994, at the Holiday Inn Crown Plaza, Regency Conference Room, 1750 
Rockville Pike, Rockville, Maryland 20852.
    This meeting will be open to the public from 9 am to 10 am to 
discuss administrative details. Attendance by the public will be 
limited to space available.
    In accordance with provisions set forth in sections 552b(c)(4) and 
552b(c)(6), title 5, U.S.C. and section 10(d) of Public Law 92-463, the 
meeting will be closed to the public on May 5 from 9 a.m. to 
adjournment for the review, discussion, and evaluation of individual 
contract proposals. These proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the proposals, disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    The Committee Management Officer, National Cancer Institute, 
Executive Plaza North, room 630, National Institutes of Health, 
Rockville, Maryland 20892, Tel. 30\1/4\96-5708, will provide a summary 
of the meeting and a roster of the committee members upon request.
    Dr. Courtney Michael Kerwin, Scientific Review Administrator, 
Developmental Therapeutics Contracts Review Committee, 6130 Executive 
Boulevard, room 609, Rockville, Maryland 20892, Tel. 30\1/4\96-7421, 
will furnish substantive program information.
    Individuals who plan to attend and need special assistance such as 
sign language interpretation or other reasonable accommodations, should 
contact Ms. Alma O. Carter, (301) 496-7523 in advance of the meeting.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control.)

    Dated: April 11, 1994.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 94-9075 Filed 4-14-94; 8:45 am]
BILLING CODE 4140-01-M